The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
Open accessAbstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus, and infections with this virus can result in acute respiratory syndrome with renal failure. Globally, MERS-CoV has been responsible for 877 laboratory-confirmed infections, including 317 deaths, since September 2012. As there is a paucity of information regarding the molecular pathogenesis associated with this virus or the identities of novel antiviral drug targets, we performed temporal kinome analysis on human hepatocytes infected with the Erasmus isolate of MERS-CoV with peptide kinome arrays. bioinformatics analysis of our kinome data, including pathway overrepresentation analysis (ORA) and functional network analysis, suggested that extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) and phosphoinositol 3-kinase (PI3K)/serine-threonine kinase (AKT)/mammalian target of rapamycin (mTOR) signaling responses were specifically modulated in response to MERS-CoV infection in vitro throughout the course of infection. The overrepresentation of specific intermediates within these pathways determined by pathway and functional network analysis of our kinome data correlated with similar patterns of phosphorylation determined through Western blot array analysis. In addition, analysis of the effects of specific kinase inhibitors on MERS-CoV infection in tissue culture models confirmed these cellular response observations. Further, we have demonstrated that a subset of licensed kinase inhibitors targeting the ERK/MAPK and PI3K/AKT/mTOR pathways significantly inhibited MERS-CoV replication in vitro whether they were added before or after viral infection. Taken together, our data suggest that ERK/MAPK and PI3K/AKT/mTOR signaling responses play important roles in MERS-CoV infection and may represent novel drug targets for therapeutic intervention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
The Severe Acute Respiratory Syndrome
Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,346
van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012) · mBio · doi:10.1128/mbio.00473-12 · Cited by 914
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Dorlo, T. P. C., Balasegaram, M., Beijnen, J. H., & de Vries, P. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks275 · Cited by 775
Protein Kinase C δ Activates the MEK-ERK Pathway in a Manner Independent of Ras and Dependent on Raf
Ueda, Y., Hirai, S.-I., Osada, S.-I., Suzuki, A., Mizuno, K., & Ohno, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23512 · Cited by 572
Knuutila, S., Björkqvist, A.-M., Autio, K., Tarkkanen, M., Wolf, M., Monni, O. M., Szymańska, J., Larramendy, M. L., Tapper, J., Pere, H., et al. (1998) · PubMed · Cited by 567
Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia
Alagaili, A. N., Briese, T., Mishra, N., Kapoor, V., Sameroff, S. C., de Wit, E., Munster, V. J., Hensley, L. E., Zalmout, I. S., Kapoor, A., et al. (2014) · mBio · doi:10.1128/mbio.00884-14 · Cited by 476
Self-citationBermingham, A., Chand, M. A., Brown, C. S., Aarons, E., Tong, C., Langrish, C., Hoschler, K., Brown, K., Galiano, M., Myers, R., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.40.20290-en · Cited by 468
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385
InnateDB: facilitating systems‐level analyses of the mammalian innate immune response
Lynn, D. J., Winsor, G. L., Chan, C., Richard, N., Laird, M. R., Barsky, A., Gardy, J. L., Roche, F. M., Chan, T. H. W., Shah, N., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.55 · Cited by 381
de Wilde, A. H., Raj, V. S., Oudshoorn, D., Bestebroer, T. M., van Nieuwkoop, S., Limpens, R. W. A. L., Posthuma, C. C., van der Meer, Y., Bárcena, M., Haagmans, B. L., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.052910-0 · Cited by 348
de Wit, E., Rasmussen, A. L., Falzarano, D., Bushmaker, T., Feldmann, F., Brining, D. L., Fischer, E. R., Martellaro, C., Okumura, A., Chang, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310744110 · Cited by 313
Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G. (2013) · mBio · doi:10.1128/mbio.00165-13 · Cited by 293
Chung, T., Lee, Y., & Kim, C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1429fje · Cited by 288
Lau, S. K. P., Li, K. S. M., Tsang, A. K. L., Lam, C. S. F., Ahmed, S., Chen, H., Chan, K.-H., Woo, P. C. Y., & Yuen, K.-Y. (2013) · Journal of Virology · doi:10.1128/jvi.01055-13 · Cited by 278
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Falzarano, D., de Wit, E., Martellaro, C., Callison, J., Munster, V. J., & Feldmann, H. (2013) · Scientific Reports · doi:10.1038/srep01686 · Cited by 273
Buchkovich, N. J., Yu, Y., Zampieri, C. A., & Alwine, J. C. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1855 · Cited by 229
MERS: emergence of a novel human coronavirus
Raj, V. S., Osterhaus, A. D., Fouchier, R. A., & Haagmans, B. L. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.01.010 · Cited by 221
Hart, B. J., Dyall, J., Postnikova, E., Zhou, H., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Frieman, M. B., Holbrook, M. R., Jahrling, P. B., et al. (2014) · Journal of General Virology · doi:10.1099/vir.0.061911-0 · Cited by 211
Self-citationKindler, E., Jónsdóttir, H. R., Muth, D., Hamming, O. J., Hartmann, R., Rodriguez, R., Geffers, R., Fouchier, R. A. M., Drosten, C., Müller, M. A., et al. (2013) · mBio · doi:10.1128/mbio.00611-12 · Cited by 202
Wang, G., Barrett, J. W., Stanford, M., Werden, S. J., Johnston, J. B., Gao, X., Sun, M., Cheng, J. Q., & McFadden, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509341103 · Cited by 194
Norman, K. L., Hirasawa, K., Yang, A.-D., Shields, M. A., & Lee, P. W. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404310101 · Cited by 189
A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway
Ehrhardt, C., & Ludwig, S. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01309.x · Cited by 167
Pyrć, K., Sims, A. M., Dijkman, R., Jebbink, M. F., Long, C., Deming, D., Donaldson, E., Vabret, A., Baric, R. S., van der Hoek, L., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00947-10 · Cited by 160
Zielecki, F., Weber, M., Eickmann, M., Spiegelberg, L., Zaki, A. M., Matrosovich, M., Becker, S., & Weber, F. (2013) · Journal of Virology · doi:10.1128/jvi.03496-12 · Cited by 158
RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade
Pleschka, S. (2008) · Biological Chemistry · doi:10.1515/bc.2008.145 · Cited by 130
PI3K-Akt Signaling and Viral Infection
Ji, W., & Liu, H. (2008) · Recent Patents on Biotechnology · doi:10.2174/187220808786241042 · Cited by 98
Mulongo, M. M., Prysliak, T., Scruten, E., Napper, S., & Perez‐Casal, J. (2013) · Infection and Immunity · doi:10.1128/iai.00961-13 · Cited by 93
Kindrachuk, J., Arsenault, R. J., KUSALIK, A. J., Kindrachuk, K. N., Trost, B., Napper, S., Jahrling, P. B., & Blaney, J. E. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015701 · Cited by 79
Self-citationLudwig, S. (2011) · Biological Chemistry · doi:10.1515/bc.2011.121 · Cited by 72
Nakamichi, K., Inoue, S., Takasaki, T., Morimoto, K., & Kurane, I. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9376-9388.2004 · Cited by 70
PIIKA 2: An Expanded, Web-Based Platform for Analysis of Kinome Microarray Data
Trost, B., Kindrachuk, J., Määttänen, P., Napper, S., & KUSALIK, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080837 · Cited by 69
Self-citationClarke, P., Leser, J. S., Bowen, R. A., & Tyler, K. L. (2014) · mBio · doi:10.1128/mbio.00902-14 · Cited by 67
A Systematic Approach for Analysis of Peptide Array Kinome Data
Li, Y., Arsenault, R. J., Trost, B., Slind, J., Griebel, P. J., Napper, S., & KUSALIK, A. J. (2012) · Science Signaling · doi:10.1126/scisignal.2002429 · Cited by 64
Qin, D., Feng, N., Fan, W., Ma, X., Yan, Q., Lv, Z., Zeng, Y., Zhu, J., & Lu, C. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-240 · Cited by 62
Bowick, G. C., Fennewald, S. M., Scott, E. P., Zhang, L.-H., Elsom, B. L., Aronson, J. F., Spratt, H. M., Luxon, B. A., Gorenstein, D. G., & Herzog, N. K. (2006) · Journal of Virology · doi:10.1128/jvi.02199-06 · Cited by 60
Emergence of the Middle East Respiratory Syndrome Coronavirus
Coleman, C. M., & Frieman, M. B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003595 · Cited by 55
Self-citationMäättänen, P., Trost, B., Scruten, E., Potter, A. A., KUSALIK, A. J., Griebel, P. J., & Napper, S. (2013) · Infection and Immunity · doi:10.1128/iai.00339-13 · Cited by 39
A novel human coronavirus: Middle East respiratory syndrome human coronavirus
Geng, H., & Tan, W.-J. (2013) · Science China Life Sciences · doi:10.1007/s11427-013-4519-8 · Cited by 34
What are our pharmacotherapeutic options for MERS-CoV?
Al‐Tawfiq, J. A., & Memish, Z. A. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.890515 · Cited by 32
Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup?
Zumla, A. I., & Memish, Z. A. (2014) · European Respiratory Journal · doi:10.1183/09031936.00227213 · Cited by 29
Cited by
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou, M., Memon, D., Meyer, B., White, K. M., Rezelj, V. V., Correa Marrero, M., Polacco, B. J., Melnyk, J. E., Ulferts, S., Kaake, R. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.034 · Cited by 1,020
Chan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K.-Y. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 881
Metadata
- Authors
- Kindrachuk, J., Ork, B., Hart, B. J., Mazur, S., Holbrook, M. R., Frieman, M. B., Traynor, D., Johnson, R. F., Dyall, J., Kuhn, J. H., Olinger, G. G., Hensley, L. E., & Jahrling, P. B.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2015-02
- Volume
- 59
- Issue
- 2
- Pages
- 1088-1099
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2133422078
- Cited by
- 407
- References
- 46
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.